Gait Parameters in Breast Cancer Receiving Chemotherapy Patients
Condition(s) studied
Investigational drug(s) / intervention(s)
Gait parameter assessment: A Biodex Gait Trainer 3 (BIODEX MEDICAL SYSTEMS, INC., New York, NY, model NO. 601-1-M90, EN 60601- 1 USA), is a device which is used to assess the spatiotemporal gait parameters of patients . It consists of a treadmill with an instrumented deck that monitors and records kinematic gait parameters including gait speed, step cycle, step length, and time on each foot (step symmetry). The patient will instructed to stand on the treadmill holding on handrails to ensure safety. Each patient will be asked to walk continuously for 3 minutes, till the evaluation session ended, and the gait trainer slow down gradually until it stopped. Three successive trials will be done for each patient. The mean value of each variable of spatiotemporal parameters of gait \[walking speed (meters per seconds), step cycle (cycle per second), step length (meter), and time on each foot (seconds)\] will be recorded.
Study summary
Breast cancer is considered the most common type of malignancies, it is the most frequently diagnosed representing around 2.3 million cases. Where, their chemotherapy may cause fatigue affecting the overall quality of patient's life. Gait and balance are fundamental for activities of daily living and maintaining functional independence.
Eligibility
Primary outcome measure(s)
- Walking Speed (Meter per second) — One time assessment throughout the study completion an average of 3 months.
Walking Speed in unit of measurement is meter per second. - Step cycle (cycle per second) — One time assessment throughout the study completion an average of 3 months.
Step cycle: in unit of measurement is Cycle per second. - Step length (Meter) — One time assessment throughout the study completion an average of 3 months.
Step length in unit of measurement is meter. - Time on each foot (Seconds) — One time assessment throughout the study completion an average of 3 months.
Time on each foot in unit of measurement is seconds
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| National Cancer Institute | Cairo | Cairo Governorate | Recruiting |
More Adly A Adam trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07894133 on ClinicalTrials.gov ↗ ← All trials in Egypt